A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine
Clinical trial NCT05149313 · COMPLETED
Trial details
- NCT number
- NCT05149313
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2023-01-30
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.